![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
20
Weistar Industry Limited Huzhou Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Paracetamol, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R0-CEP 2006-156 - Rev 00
This Chemical Type CEP, issued on April 17, 2008, remains in force until April 16, 2013, ensuring its reliability within the pharmaceutical industry.
Substance Number 49 associated with this CEP further emphasizes